PRESS RELEASE

Evolucare Group issues its first bond to accelerate its growth

RELEASE : November 9th, 2021

  • Share this post :
Evolucare prêt obligataire

Le Pecq, November 9th, 2021

Evolucare is proud to announce the success of its €18 million financing with institutional investors through a private placement in a Euro PP bond format.

These funds will enable the group to accelerate its growth in its core business, in innovation and in its international ambitions. This growth will be achieved organically by financing the group’s transformation in its most strategic markets, and will also be achieved through external growth. Acquisitions along these lines will be announced shortly.
The bond issue, with a 7-year maturity and redeemable at maturity, is also structured with ESG performance indicators (Sustainability-linked Bond format) reflecting the Evolucare group’s strong and ambitious commitment to Corporate Social Responsibility.

Our partner Essling Capital and the Evolucare team would like to thank Crédit Agricole Brie Picardie, Evolucare’s first banking partner, Crédit Agricole CIB for its role as arranger and ESG structurer, and our new financial partners Aviva Investors France and Tikehau Capital.

“Thanks to this investment, Evolucare will reach the critical size that will allow it to position itself as a key player in the healthcare software industry on a European scale,” said Elie Le Guilcher, Founder and Chairman of Evolucare Group.

 

“This round of financing marks a new stage in the group’s growth. It allows us to strengthen the competitiveness of our solutions in our historical markets and to strategically position the group to prepare the healthcare solutions of tomorrow” adds Philippe Blanco, CEO of the Evolucare group.

 

“This successful transaction confirms Evolucare’s credit quality well received by top tier investors for a successful French growing company operating in the dynamic healthcare software market” concludes Thong Nguon, Executive Director Debt Capital Markets at Crédit Agricole CIB.

We would also like to thank Gide Loyrette Nouel A.A.R.P.I, legal advisor to the transaction, and Lys Avocats.

Download the press release (french)

 

Discover Evolucare

International strategy

Evolucare Labs

Our Expertise
5

Production

5

Projects & Deployment

5

Interoperability

5

Customer service

5

Quality & Safety

Our partners
Working at Evolucare

Hospitals / Clinics

Critical Care

5

Surgical Process

5
Anesthesia
5
Intensive Care
Medical Imaging
5
RIS-PACS
5
Consoles
5
Sharing
5
Teleradiology
Ophtalmologie-IA

Ophthalmology

Nursing Home
5

Disabled People

5
Elderly People
5
HR & Scheduling
5
Management
Sie werden auf die Website OPHTAI.COM der Evolucare-Gruppe weitergeleitet.
You will be redirected to the OPHTAI.COM website of Evolucare Group.
Vous allez être redirigé sur le site OPHTAI.COM du Groupe Evolucare.

Evolucare entdecken

Internationale Strategie

Evolucare Labs

Unsere kompetenzen

5

Produktion

5

Projekte & Implementierung

5

Interoperabilität

5

Kundenservice

5

Qualität - Sicherheit

Partnernetzwerk

Arbeiten bei Evolucare

Découvrir Evolucare

Nos partenaires

Nos formations

Evolucare Labs

Expertises et métiers

5

Recherche et Développement

5

Projets et déploiement

5

Interopérabilité

5

Service client & support

5

Qualité et sécurité

Travailler chez Evolucare

Carrières (Indeed)

Krankenhause

Intensivpflege

5

Chirurgischen Prozesses

5
Anästhesieakte
5
Intensivstationen
Medizinische Bildgebung
5
RIS-PACS
5
Bildschirm-Konsole
5
Verbreitung
5
Teleradiologie
Ophtalmologie-IA

Ophthalmologie

Sozialer Pflegebereich
5

Behinderungen

5
Ältere Leute
5
Personalwesen
5
Verwaltung
Médico-Social
5
DUI Handicap
5
EHPAD
5
ARGOSS
5
RH & Planning
5
Gestion

Sanitaire

Soins critiques

5
Processus chirurgical
5
Anesthésie
5
Réanimation
Imagerie médicale
5
RIS-PACS-MACS
5
Consoles
5
Diffusion
5
Téléradiologie
5
Modules connectés
Ophtalmologie-IA

Ophtalmologie